Jason Wittes
Stock Analyst at Roth MKM
(3.06)
# 1,245
Out of 4,873 analysts
62
Total ratings
48.15%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $379.16 | +20.27% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.41 | +563.90% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $2.80 | +92.86% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.71 | +835.67% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $10.80 | +103.80% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $59.50 | +21.02% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $5.29 | +107.94% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $57.81 | +98.93% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $6.65 | +441.76% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $6.45 | +70.54% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.28 | +681.25% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $83.38 | +19.93% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.11 | +136.97% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.25 | +620.00% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $29.96 | +150.33% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $10.86 | +102.58% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $91.50 | +31.15% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $168.22 | +22.46% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $221.34 | -34.49% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.49 | +30.55% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $16.61 | +1,104.09% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $36.56 | -28.88% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $379.16
Upside: +20.27%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.41
Upside: +563.90%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $2.80
Upside: +92.86%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.71
Upside: +835.67%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $10.80
Upside: +103.80%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $59.50
Upside: +21.02%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.29
Upside: +107.94%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $57.81
Upside: +98.93%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $6.65
Upside: +441.76%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $6.45
Upside: +70.54%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $83.38
Upside: +19.93%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.11
Upside: +136.97%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.25
Upside: +620.00%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $29.96
Upside: +150.33%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $10.86
Upside: +102.58%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $91.50
Upside: +31.15%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $168.22
Upside: +22.46%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $221.34
Upside: -34.49%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $11.49
Upside: +30.55%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $16.61
Upside: +1,104.09%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $36.56
Upside: -28.88%